Verastem (VSTM) Stock: Buy, Sell, or Hold?
$9.09
+0.36 (+4.12%)
â˛
5d:
-7.72%
30d:
+22.01%
90d:
+36.28%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect VSTM Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (55%)
Quality Score
49/100
Position
FAIR
30-Day Fair Range
$8.20 â $9.80
Position: FAIR
Forward P/E & Valuation
-7.5x
Next 12M consensus est.
Wall Street Target
$17.22
+89.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$7.72 / $10.10
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: VSTM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 10, 2026 at $8.71 · last confirmed Nov 10, 2026
Strength: 7.8/10
Get Alerted When VSTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: VSTM is currently trading at $9.09, which is considered fair relative to its 30-day fair value range of $8.20 to $9.80.
Technical Outlook: Technically, VSTM is in a strong uptrend. Immediate support is located at $7.72, while resistance sits at $10.10. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: VSTM scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.22 (+89.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VSTM is in a strong uptrend. Immediate support is located at $7.72, while resistance sits at $10.10. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: VSTM scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.22 (+89.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$8.20 -
$9.80
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.3%
Trading Range & Key Levels
30-Day Trading Range
$8.20 -
$9.80
Current vs Trading Range
FAIR
Support Level
$7.72
Resistance Level
$10.10
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding VSTM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.1%)
- BULLISH: Trading 89.5% below Wall St target ($17.22)
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-7.45
Wall Street Target
$17.22
(+89.5%)
Revenue Growth (YoY)
113.6%
Profit Margin
-178.4%
Share VSTM Analysis
Share this live VSTM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (VSTM)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Verastem aims for accelerated approval of pancreatic cancer drug VS-7375 in Q2 2023, with potential expansion into colorectal and lung cancers. The drug showed a 41% response rate in previously treated patients and a 67% six-month progression-free survival rate.
Key Retail Themes:
Regulatory approval timeline
Drug response rates
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:06 AM ET
Data refreshes hourly during market hours. Next update: 8:06 AM
Data refreshes hourly during market hours. Next update: 8:06 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VSTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 61 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$689 | 56 HOLD |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 63 BUY |
Advanced VSTM Option Strategies
Professional options setups generated by AI based on today's VSTM price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive VSTM Research Pages
